Document is current

Any future updates will be listed below

FDA’s New Guidance for Industry Addressing Evaluation of the Safety of New Drugs for Improving Glycemic Control: A Case Study in Regulatory Science

Crossref DOI link: https://doi.org/10.1007/s43441-020-00211-6

Published Online: 2020-10-21

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark